XBIO
Xenetic Biosciences Inc
NASDAQ: XBIO · HEALTHCARE · BIOTECHNOLOGY
$3.03
+1.00% today
Updated 2026-04-30
Market cap
$6.87M
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$2 – $14
Volume
0.0M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+5.0
Quality
C+2.0
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$40.00
+1220.13%
12-Month target
—
—
Intrinsic (DCF)
$12.86
Margin of safety
+83.36%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 18.10% QoQ
+ 83.36% below intrinsic value
Risks
- Thin margins at -90.10%
- Negative free cash flow $-242682.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.71M | $2.54M | $2.50M | $2.98M | $2.98M |
| Net income | $-6.55M | $-4.13M | $-3.96M | $-2.68M | $-579076.00 |
| EPS | — | — | — | — | $-1.58 |
| Free cash flow | $-5.15M | $-4.11M | $-2.82M | $-2.29M | $-242682.00 |
| Profit margin | -383.87% | -162.78% | -158.39% | -90.07% | -90.10% |
Peer comparison
Smart narrative
Xenetic Biosciences Inc trades at $3.03. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $2.98M. with profit margins at -90.10%. Our DCF model estimates intrinsic value at $12.86.
Frequently asked questions
What is Xenetic Biosciences Inc's stock price?
Xenetic Biosciences Inc (XBIO) trades at $3.03.
Is Xenetic Biosciences Inc overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell). DCF value $12.86.
What is the price target of Xenetic Biosciences Inc (XBIO)?
The analyst target price is $40.00, representing +1220.1% upside from the current price of $3.03.
What is the intrinsic value of Xenetic Biosciences Inc (XBIO)?
Based on our DCF model, intrinsic value is $12.86, a +83.4% margin of safety versus $3.03.
What is Xenetic Biosciences Inc's revenue?
TTM revenue is $2.98M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.31x
ROE-40.00%
Beta2.21
50D MA$2.86
200D MA$2.96
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—